Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0106401001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02537257 | JANSSEN INC | FINLIUS | Human | Yes | Prescription | 1 | USTEKINUMAB | 90 MG / 1 ML |
Marketed | 02537257 | JANSSEN INC | FINLIUS | Human | Yes | Schedule D | 1 | USTEKINUMAB | 90 MG / 1 ML |
Marketed | 02537303 | JANSSEN INC | FINLIUS | Human | Yes | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02537303 | JANSSEN INC | FINLIUS | Human | Yes | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02543036 | JAMP PHARMA CORPORATION | JAMTEKI | Human | Yes | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02543036 | JAMP PHARMA CORPORATION | JAMTEKI | Human | Yes | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02543044 | JAMP PHARMA CORPORATION | JAMTEKI | Human | Yes | Schedule D | 1 | USTEKINUMAB | 90 MG / 1 ML |
Marketed | 02543044 | JAMP PHARMA CORPORATION | JAMTEKI | Human | Yes | Prescription | 1 | USTEKINUMAB | 90 MG / 1 ML |
Approved | 02554283 | FRESENIUS KABI CANADA LTD | OTULFI | Human | Yes | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Approved | 02554283 | FRESENIUS KABI CANADA LTD | OTULFI | Human | Yes | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Approved | 02554291 | FRESENIUS KABI CANADA LTD | OTULFI | Human | Yes | Schedule D | 1 | USTEKINUMAB | 90 MG / ML |
Approved | 02554291 | FRESENIUS KABI CANADA LTD | OTULFI | Human | Yes | Prescription | 1 | USTEKINUMAB | 90 MG / ML |
Approved | 02550539 | SAMSUNG BIOEPIS CO., LTD | PYZCHIVA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Approved | 02550539 | SAMSUNG BIOEPIS CO., LTD | PYZCHIVA | Human | Yes | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Approved | 02550547 | SAMSUNG BIOEPIS CO., LTD | PYZCHIVA | Human | Yes | Prescription | 1 | USTEKINUMAB | 90 MG / 1 ML |
Approved | 02550547 | SAMSUNG BIOEPIS CO., LTD | PYZCHIVA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 90 MG / 1 ML |
Marketed | 02320673 | JANSSEN INC | STELARA | Human | Yes | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02320673 | JANSSEN INC | STELARA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02320681 | JANSSEN INC | STELARA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 90 MG / 1 ML |
Marketed | 02320681 | JANSSEN INC | STELARA | Human | Yes | Prescription | 1 | USTEKINUMAB | 90 MG / 1 ML |
Marketed | 02550245 | CELLTRION INC. | STEQEYMA | Human | Yes | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02550245 | CELLTRION INC. | STEQEYMA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02550253 | CELLTRION INC. | STEQEYMA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 90 MG / 1 ML |
Marketed | 02550253 | CELLTRION INC. | STEQEYMA | Human | Yes | Prescription | 1 | USTEKINUMAB | 90 MG / 1 ML |
Marketed | 02544180 | AMGEN CANADA INC | WEZLANA | Human | Yes | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02544180 | AMGEN CANADA INC | WEZLANA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02544199 | AMGEN CANADA INC | WEZLANA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 90 MG / 1 ML |
Marketed | 02544199 | AMGEN CANADA INC | WEZLANA | Human | Yes | Prescription | 1 | USTEKINUMAB | 90 MG / 1 ML |
Marketed | 02544202 | AMGEN CANADA INC | WEZLANA | Human | Yes | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02544202 | AMGEN CANADA INC | WEZLANA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02553309 | AMGEN CANADA INC | WEZLANA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 90 MG / 1 ML |
Marketed | 02553309 | AMGEN CANADA INC | WEZLANA | Human | Yes | Prescription | 1 | USTEKINUMAB | 90 MG / 1 ML |
Marketed | 02553317 | AMGEN CANADA INC | WEZLANA | Human | Yes | Prescription | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Marketed | 02553317 | AMGEN CANADA INC | WEZLANA | Human | Yes | Schedule D | 1 | USTEKINUMAB | 45 MG / 0.5 ML |
Application information
Related information
Contact us
Version 4.0.3